NCT00228423View on ClinicalTrials.gov

Trial of Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial)

PHASE2CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

July 31, 2009

Conditions
Atherosclerosis
Interventions
DRUG

Clopidogrel 75 mg daily

Daily dose of 75 mg Clopidogrel

DRUG

water pill daily

Daily dose of water pill (placebo)

Trial Locations (1)

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

Sponsors
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Ottawa Heart Institute Research Corporation

OTHER

NCT00228423 - Trial of Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial) | Biotech Hunter | Biotech Hunter